Roger Clark is an Infectious Disease physician affiliated with Massachusetts General Hospital. OpenAlex indexes 34 publications with 711 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1153 Centre St
Suite 4955
Boston, MA 021303446
Telephone
617-522-4943Registry record last updated 18 Jun 2008.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
83.8%Penicillins with extended spectrum17.6%Amoxicillin100%Part D<11 patientsTetracycline-class Drug17.6%Doxycycline Monohydrate100%Part D<11 patients+ 3 more classes in this area
Hormonal (systemic)
16.2%l-Thyroxine16.2%Levothyroxine Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Visible-infrared Spectra of keV Electron Irradiated Cryogenic Salts with Implications for Europa Surface Composition
The Planetary Science Journal
2025 - Chemical Biology Approaches Confirm MCT4 as the Therapeutic Target of a Cellular Optimized Hit
ACS Chemical Biology
2023 - Discovery of Clinical Candidate AZD0095, a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for Oncology
Journal of Medicinal Chemistry
2022 - Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission
Nature Communications
2022
Similar KOLs
Other experts from the same institution or the same specialty.
James Januzzi, MD
Massachusetts General Hospital
Maurizio Fava, MD
Massachusetts General Hospital
Steven Greenberg, MD
Massachusetts General Hospital
David Scadden, MD
Massachusetts General Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”